Creating Biosimilars Is So Much More Than Copy and Paste
Highly Similar
Biosimilars have the potential to expand patient access to more treatment options, but creating them is anything but copy and paste.
AD BY Pfizer
Medicines produced from the cells of living organisms are called biologics. They’re typically more difficult to manufacture than small-molecule drugs, and generics, or exact copies, can’t be produced.